Michael Scolaro

Michael Scolaro

Oct 20, 2017

Group 6 Copy 13
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Do fungi exposed to toxic waste produce novel antimicrobial agents?

    We've discovered a few new mushrooms thriving in this harsh environment of land-disposed sewage sludge in...

    A Prescription for Health and Fitness Based on Your Genes

    Exercise has many health benefits. Yet, most people stop their exercise programs after they start them...

    Modeling Zika virus transmission from mother to child using uterine mini-organs

    As of mid-2019, 87 countries have had or still have Zika cases, underlining the importance of this infectious...

    Backer Badge Funded